Active substance against neutropenia (clinical research of the active substance Myelo001 in the indication chemotherapy induced neutropenia) (Q3313537)

From EU Knowledge Graph
Jump to navigation Jump to search
Project Q3313537 in Germany
Language Label Description Also known as
English
Active substance against neutropenia (clinical research of the active substance Myelo001 in the indication chemotherapy induced neutropenia)
Project Q3313537 in Germany

    Statements

    0 references
    0 references
    511,075.0 Euro
    0 references
    638,843.75 Euro
    0 references
    80.0 percent
    0 references
    6 January 2015
    0 references
    30 April 2018
    0 references
    ABX CRO advanced pharmaceu-tical services Forschungs-gesellschaft mbH
    0 references
    0 references
    0 references

    51°2'57.59"N, 13°44'17.30"E
    0 references
    Wirkstoff gegen Neutropenie (Klinische Erforschung des Wirkstoffes Myelo001 in der Indikation Chemotherapie- induzierte Neutropenie) (German)
    0 references
    Active substance against neutropenia (clinical research of the active substance Myelo001 in the indication chemotherapy induced neutropenia) (English)
    25 October 2021
    0.0059835763390727
    0 references
    Principe actif contre la neutropénie (recherche clinique du principe actif Myelo001 dans l’indication de la neutropénie induite par la chimiothérapie) (French)
    6 December 2021
    0 references
    Werkzame stof tegen neutropenie (klinische studie van de werkzame stof Myelo001 bij de indicatie chemotherapie geïnduceerde neutropenie) (Dutch)
    19 December 2021
    0 references
    Principio attivo contro la neutropenia (ricerca clinica del principio attivo Myelo001 nell'indicazione neutropenia indotta da chemioterapia) (Italian)
    19 January 2022
    0 references
    Principio activo contra neutropenia (investigación clínica del principio activo Myelo001 en la indicación de neutropenia inducida por quimioterapia) (Spanish)
    22 January 2022
    0 references
    Δραστική ουσία κατά της ουδετεροπενίας (κλινική έρευνα της δραστικής ουσίας Myelo001 στην ένδειξη που προκαλείται από χημειοθεραπεία ουδετεροπενία) (Greek)
    19 August 2022
    0 references
    Aktivt stof mod neutropeni (klinisk forskning af det aktive stof Myelo001 i indikationen kemoterapi induceret neutropeni) (Danish)
    19 August 2022
    0 references
    Vaikuttava aine neutropeniaa vastaan (vaikuttavan aineen Myelo001 kliininen tutkimus solunsalpaajahoidon indusoiman neutropenian käyttöaiheessa) (Finnish)
    19 August 2022
    0 references
    Sustanza attiva kontra n-newtropenja (riċerka klinika tas-sustanza attiva Myelo001 fl-indikazzjoni newtropenija kkaġunata mill-kimoterapija) (Maltese)
    19 August 2022
    0 references
    Aktīvā viela pret neitropēniju (klīniskie pētījumi par aktīvo vielu Myelo001 ķīmijterapijas izraisītas neitropēnijas gadījumā) (Latvian)
    19 August 2022
    0 references
    Liečivo proti neutropénii (klinický výskum liečiva Myelo001 v indikácii neutropénie vyvolanej chemoterapiou) (Slovak)
    19 August 2022
    0 references
    Substaint ghníomhach i gcoinne neutropenia (taighde cliniciúil ar an tsubstaint ghníomhach Myelo001 sa cheimiteiripe léirithe a spreagtar neutropenia) (Irish)
    19 August 2022
    0 references
    Léčivá látka proti neutropenii (klinický výzkum účinné látky Myelo001 v indikaci neutropenie indukované chemoterapií) (Czech)
    19 August 2022
    0 references
    Substância ativa contra a neutropenia (investigação clínica da substância ativa Myelo001 na indicação neutropenia induzida por quimioterapia) (Portuguese)
    19 August 2022
    0 references
    Toimeaine neutropeenia vastu (toimeaine Myelo001 kliinilised uuringud keemiaravi indutseeritud neutropeenia näidustusel) (Estonian)
    19 August 2022
    0 references
    Hatóanyag neutropenia ellen (a Myelo001 hatóanyag klinikai vizsgálata kemoterápia indukálta neutropenia indikációban) (Hungarian)
    19 August 2022
    0 references
    Активно вещество срещу неутропения (клинични изследвания на активното вещество Myelo001 при показанието химиотерапия, индуцирана неутропения) (Bulgarian)
    19 August 2022
    0 references
    Veiklioji medžiaga prieš neutropeniją (klinikiniai veikliosios medžiagos Myelo001 tyrimai su chemoterapijos sukelta neutropenija) (Lithuanian)
    19 August 2022
    0 references
    Djelatna tvar protiv neutropenije (klinička istraživanja djelatne tvari Myelo001 u indikaciji neutropenije izazvane kemoterapijom) (Croatian)
    19 August 2022
    0 references
    Aktiv substans mot neutropeni (klinisk forskning om den aktiva substansen Myelo001 vid indikationen kemoterapi inducerad neutropeni) (Swedish)
    19 August 2022
    0 references
    Substanță activă împotriva neutropeniei (cercetare clinică a substanței active Myelo001 în neutropenia indusă de chimioterapie cu indicație) (Romanian)
    19 August 2022
    0 references
    Zdravilna učinkovina proti nevtropeniji (klinične raziskave zdravilne učinkovine Myelo001 za indikacijo nevtropenija, povzročena s kemoterapijo) (Slovenian)
    19 August 2022
    0 references
    Substancja czynna przeciwko neutropenii (badania kliniczne substancji czynnej Myelo001 we wskazaniu dotyczącym neutropenii wywołanej chemioterapią) (Polish)
    19 August 2022
    0 references
    Dresden, Stadt
    0 references

    Identifiers

    672 / 101002072451
    0 references